Clinical Trial Update: Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2 [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial investigating recovery of damaged cells to address post-COVID-19 sequelae and related conditions. Current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depression Anxiety
• Depression Bipolar
• Gastroesophageal Reflux
• Glomerulonephritis
• Insomnia
• Major Depressive Disorder
• Post Infectious Osteoarthritis
• Post-infectious Arthritis
• Post-infectious Disorder
• Post-infectious Glomerulonephritis
• Post-infectious Hypothyroidism
• Post-infectious Parkinsonism
• Post-infectious Peripheral Neuralgia
• Post-infectious Polyneuritis
• Sequelae of Infection
• Viral Hepatitis

Snippet

Sponsor: All Natural Medicine Clinic, LLC | Conditions: Sequelae of; Infection, Post Infection Glomerulonephritis | Phase 1, Phase 2 | Status: UNKNOWN